LSV Asset Management
AUPH icon

LSV Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

LSV Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.3M Buy
1,807,712
+728,265
+67% +$11.6M 0.05% 298
2026
Q2 		$18.3M Buy
1,079,447
+39,871
+4% +$637K 0.03% 356
2026
Q1 		$15.4M Buy
1,039,576
+382,729
+58% +$5.59M 0.03% 347
2025
Q4 		$10.5M Buy
+656,847
New +$9.31M 0.02% 381

Other funds holding AUPH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Hussman Strategic Advisors
Hussman Strategic Advisors Ellicott City, Maryland $469M AUM 10.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

LSV Asset Management's AUPH Position: Q3 2026 in Review

LSV Asset Management increased its Aurinia Pharmaceuticals (AUPH) stake by 67% in Q3 2026, buying an estimated $11.6M and bringing the position to 1,807,712 shares worth $29.3M. The position accounts for 0.05% of the portfolio, ranked #298.

LSV Asset Management first reported a position in AUPH in Q4 2025 and has held it in 4 quarters since. 102 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • LSV Asset Management held 1,807,712 shares of Aurinia Pharmaceuticals worth $29.3M as of Q3 2026.
  • LSV Asset Management bought 728,265 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $11.6M.
  • Aurinia Pharmaceuticals made up 0.05% of LSV Asset Management's portfolio in Q3 2026, its #298 holding.
  • LSV Asset Management first reported a position in Aurinia Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 102 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on LSV Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.